Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Dublin, April 16, 2026 (GLOBE NEWSWIRE) -- The "Measuring Performance in Clinical Research Management (May 6, 2026)" training has been added to ResearchAndMarkets.com's offering. This...
-
A new white paper has been released which heralds the dawn of a new era of treatment for knee osteoarthritis
-
Dublin, April 15, 2026 (GLOBE NEWSWIRE) -- The "An Overview of Ethical Standards in Clinical Research Publication (May 13, 2026)" training has been added to ResearchAndMarkets.com's offering. ...
-
Dublin, April 14, 2026 (GLOBE NEWSWIRE) -- The "Clinical Research Project Management (April 29, 2026 and May 1, 2026)" training has been added to ResearchAndMarkets.com's offering.This interactive...
-
Dublin, April 14, 2026 (GLOBE NEWSWIRE) -- The "Pharmaceutical Regulatory Affairs in China (June 3rd - June 4th, 2026)" training has been added to ResearchAndMarkets.com's offering. This...
-
Dublin, April 14, 2026 (GLOBE NEWSWIRE) -- The "AI & ML in Clinical Trials: Fundamentals, Applications, and Regulatory Aspects (May 11, 2026)" training has been added to ...
-
Dublin, April 13, 2026 (GLOBE NEWSWIRE) -- The "GCP and Clinical Research Update: What Inspectors Are Focusing on Now (May 19, 2026)" training has been added to ResearchAndMarkets.com's...
-
Tekton Research announces the opening of its San Antonio research hub, a physician-led clinical research center.
-
Des études de phase 2 sur le lunsekimig ont atteint les critères d’évaluation principaux et secondaires clés dans deux maladies respiratoires
-
Phase 2 studies of lunsekimig, a novel bispecific nanobody, met primary and key secondary endpoints in two chronic respiratory conditions.